Who Pays for Patient Care 100 Years From Now?

What stays with you after you think about a patient who will wake up long after you’re gone is not the science. It’s the money that lets the science happen. The idea of cryonics asks for faith in technology, yes. But it also asks for a plan that outlives the present tense. I’m sixty three and I have watched plans fray when money tightens and institutions stumble. So I start with a simple question, the one I keep returning to as I sort through long horizons: who pays for patient care a century from now?

I’ve seen a lot of talk about funds, bonds, and endowments that are supposed to outlast a few political cycles. In the world I know, a patient-care fund is not a candle in the wind. It’s a stack of promises, wrapped in legal documents, audited numbers, and the quiet fear that inflation will gnaw at the principle. The patient-care fund is where preservation meets the daily grind of expenses: staffing, facilities, energy bills, and the ticking clock that tells you every year the care you counted on costs more. If you want a future for someone who is frozen or preserved, you need someone to pay for the care when the body, or the science, or the system changes shape.

Governance is the shadow that decides whether a fund survives. A fund needs rules, but it also needs people who will enforce them when nerves fray and pressures mount. In the current climate, governance means boards with fiduciary duties and independent audits, but also resilience against political shifts and market shocks. It means there is somebody who can say no when a shiny new scheme promises easy returns or a flashy vendor shows up with a cheaper bill that quietly shifts risk across the ledger. I’m wary of promises dressed as moral imperatives. A fund that lasts must be boring in the right places: boring in risk assessment, boring in compliance, boring in disclosures that never end up in a marketing deck.

Investment assumptions are where the ideal meets the ground. The people who design long-term funds assume a rate of return, a rate of cost increase, a probability of failure, a probability of revival. They assume future cash flows from donors, or future reimbursements from some form of societal care model. The trouble is the future does not come with a disclaimer. It comes with tax changes, interest-rate swings, and new ways to monetize risk. A fund that survives a century cannot count on a single engine of growth. It needs room to breathe: diversified holdings, liquidity cushions, and the humility to adjust targets as the world shifts. Inflation is the weather that never stops. If the fund is too optimistically invested, it will wither when prices rise and medical costs leap ahead of the plan. If it’s too cautious, it might stagnate and drift past the point of usefulness. The balance is not a line on a chart; it is a culture in the room, a willingness to redraw the map when the terrain changes.

Maintenance is the quiet work that keeps a promise from turning hollow. It isn’t glamorous to talk about software licenses, facility maintenance, and the cost of keeping a cryonics facility sanitary and secure. Yet without it, the dream dies inside a locked door. Maintenance asks for a budget that includes routine replacement, cybersecurity, and the costs of compliance with whatever laws exist now and whatever laws show up later. A century of care means you can’t pretend things stay the same. It means planning for the day when the original founders are gone, and new stewards must stand up with the same mandate. Maintenance is the stubborn commitment to keeping the lights on and the records intact so someone can find a way back to life when the time comes.

Institutional risk is the gravity that heavy up over the best-laid plans. A fund can be prudent, well-managed, and ethical, and still fail if the institution around it collapses. Hospitals shutter, regulators change the rules, reputations crumble, and the people who depend on care discover the system was built with a certain buyer’s gravity in mind—one that doesn’t always hold in a crisis. A century from now, risk isn’t just about market drop or a bad investment year. It’s about the viability of a whole ecosystem: the ability to attract staff, to maintain facilities, to negotiate with insurers or governments, to defend the product in the public square when fear and misinformation rise. If you want patient care to endure, you must insist on institutional resilience: cross-checked legal frameworks, redundant governance, and paths for continuity when leadership turns over.

The patient-care fund has to learn from the past without being trapped by it. I hear claims that a fund can guarantee care forever if it just sticks to a clever blueprint today. Then I see the mechanics of the blueprint: a legal entity, an investment policy, a spending rule, a governance charter. The plan is only as strong as the people who steward it and the laws that allow the plan to survive misfortune. There is a temptation to overpromise. The human urge to assure someone that a century of care is possible leads to gloss and glossing over inconvenient forces: inflation, governance drift, and the fragility of institutions that rely on the goodwill of a few. Skepticism isn’t a refusal to hope. It’s a demand for honesty about the debt load of a promise and the complexity of keeping it in a world that is always changing its mind about health, aging, and risk.

There is a certain pragmatism that scares away dreamers. If you want patient care 100 years from now, you need a structure that does not depend on any single leader or a single market condition. The fund must withstand the loss of a charismatic founder, the siphoning off of donors by a charismatic rival, and the moment when a new technology that seems to offer a shortcut makes the old plan look quaint. A long-term patient-care fund must be transparent about what it can and cannot guarantee. It should publish its assumptions and its sensitivities, the kinds of shocks that would force a reset, and the rules for adjusting goals when reality shifts. The more the fund hides its risks, the more fragile it becomes when the wind shifts.

I have spent years listening to discussions that begin with grand claims about human longevity and end with the same twist: cost matters. The math always arrives late to the party, but it arrives with a demand for discipline. The ideal of preserving a person while their world moves on is noble, but the practical world runs on budgets and schedules. If the patient-care fund cannot endure the daily friction of inflation, maintenance, and governance, it becomes a museum piece rather than a living option. And then what? The patient wakes up, but the system cannot support the care they expected, so the promise falters at the door.

So I watch the conversation as a consumer who wants a fair hearing. Cryonics deserves a hearing. The claims have to be measured, the costs named honestly, and the cases presented with the same caution you’d apply to any long-term obligation. I do not want to be sold a moon shot dressed in a charity band. I want to know how the funding holds up when a century of expenses unfolds, when inflation doubles down, when an institution’s staff turns over, or when a new regulation reshapes the game. The people who design these plans must be prepared to adapt without losing core commitments. They must document how they will protect patient records, how they will secure facilities, how they will preserve the chain of custody for expensive equipment and delicate specimens, and how they will ensure that a century of care remains affordable for the next generation—the people who will face their own budgets, their own inflation, their own political storms.

There is another angle that cannot be ignored. The families who will navigate this work are not passive. They will demand accountability, and rightly so. They will compare promises to outcomes, and they will push for clauses that protect patients when the system strains. The governance must accommodate such pressure without collapsing into blame games or unwieldy bureaucracy. A living system needs voices from the outside—the auditors, the patient-rights advocates, the independent researchers who can poke holes in the plan without personal rancor. A century-long promise should not hinge on a single rumor of efficiency or a single optimistic projection. It needs multiple pathways, with clear exit ramps and recovery routes when timelines slip and costs climb.

In the end, this is not about what cryonics can guarantee in a vacuum. It is about what a society will be willing to fund when the future arrives with its own demands and its own costs. A patient-care fund is a covenant that the present makes with the future—a vow that we will try to stand up when the world has moved on. That intent deserves scrutiny. It deserves the hard questions about governance and inflation and maintenance. It deserves a clear acknowledgment of risk, not a glossy gloss that invites more risk by hiding it.

The only useful conclusion I keep circling back to is this: the promise lasts only as long as the will to sustain it and the capacity to pay for it. If those two things erode, the promise dissolves long before the patient does. And if the fund can survive the test, if governance remains honest, if investment assumptions hold up under pressure, if inflation is managed with prudence, and if maintenance is treated as a core obligation rather than a courtesy, then the dream survives long enough for someone to reach a future we cannot fully imagine.

That is the measure I want to see. Not a flashy sales pitch, not a count of “guarantees,” but a living document of resilience. A plan that translates ideals into a structure sturdy enough to outlive the people who built it. If cryonics asks for a century of care, it must show a century of stewardship.

Then the present meets the long arc of the future, and we watch how the funding promise holds up when the preservation promise begins to play out. Now we see whether the system can keep its nerve, and whether the patient can rely on a plan that still breathes when the world around it changes its mind.

Forever. That word should stand up to scrutiny, not guesswork.

Then / Now / Forever.